Literature DB >> 15191918

Enhanced monocyte chemoattractant protein-3/CC chemokine ligand-7 in usual interstitial pneumonia.

Esther S Choi1, Claudia Jakubzick, Kristin J Carpenter, Steven L Kunkel, Holly Evanoff, Fernando J Martinez, Kevin R Flaherty, Galen B Toews, Thomas V Colby, Ella A Kazerooni, Barry H Gross, William D Travis, Cory M Hogaboam.   

Abstract

Chemokines are increased and may exert effects on both inflammatory and remodeling events in idiopathic pulmonary pneumonia (IIP). Accordingly, we examined the concomitant expression of inflammatory CC chemotactic cytokines or chemokines and their corresponding receptors in surgical lung biopsies obtained at the time of disease diagnosis and pulmonary fibroblasts grown from these biopsies. By gene array analysis, upper and lower lobe biopsies and primary fibroblast lines from patients with usual interstitial pneumonia (UIP), nonspecific interstitial pneumonia, and respiratory bronchiolitis-interstitial lung disease, but not patients without IIP, exhibited CCL7 gene expression. TAQMAN, immunohistochemical, and ELISA analyses confirmed that CCL7 was expressed at significantly higher levels in UIP lung biopsies compared with biopsies from patients with nonspecific interstitial pneumonia, respiratory bronchiolitis-interstitial lung disease, and from patients without IIP. Higher levels of CCL7 were present in cultures of IIP fibroblasts compared with non-IIP fibroblasts, and CCL5, a CCR5 agonist, significantly increased the synthesis of CCL7 by UIP fibroblasts. Together, these data suggest that CCL7 is highly expressed in biopsies and pulmonary fibroblast lines obtained from patients with UIP relative to patients with other IIP and patients without IIP, and that this CC chemokine may have a major role in the progression of fibrosis in this IIP patient group.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15191918     DOI: 10.1164/rccm.200401-002OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  18 in total

1.  Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia.

Authors:  E S Choi; E M Pierce; C Jakubzick; K J Carpenter; S L Kunkel; H Evanoff; F J Martinez; K R Flaherty; B B Moore; G B Toews; T V Colby; E A Kazerooni; B H Gross; W D Travis; C M Hogaboam
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

Review 2.  Gene expression profiling as a window into idiopathic pulmonary fibrosis pathogenesis: can we identify the right target genes?

Authors:  Naftali Kaminski; Ivan O Rosas
Journal:  Proc Am Thorac Soc       Date:  2006-06

Review 3.  Towards systems biology of human pulmonary fibrosis.

Authors:  Sean M Studer; Naftali Kaminski
Journal:  Proc Am Thorac Soc       Date:  2007-01

4.  Three Unique Interstitial Macrophages in the Murine Lung at Steady State.

Authors:  Sophie L Gibbings; Stacey M Thomas; Shaikh M Atif; Alexandra L McCubbrey; A Nicole Desch; Thomas Danhorn; Sonia M Leach; Donna L Bratton; Peter M Henson; William J Janssen; Claudia V Jakubzick
Journal:  Am J Respir Cell Mol Biol       Date:  2017-07       Impact factor: 6.914

5.  Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis.

Authors:  Masaru Uchida; Hiroshi Shiraishi; Shoichiro Ohta; Kazuhiko Arima; Kazuto Taniguchi; Shoichi Suzuki; Masaki Okamoto; Shawn K Ahlfeld; Koichi Ohshima; Seiya Kato; Shuji Toda; Hironori Sagara; Hisamichi Aizawa; Tomoaki Hoshino; Simon J Conway; Shinichiro Hayashi; Kenji Izuhara
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-12       Impact factor: 6.914

6.  Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis.

Authors:  Moises Selman; Annie Pardo; Lourdes Barrera; Andrea Estrada; Susan R Watson; Keith Wilson; Natasha Aziz; Naftali Kaminski; Albert Zlotnik
Journal:  Am J Respir Crit Care Med       Date:  2005-09-15       Impact factor: 21.405

7.  An SFTPC BRICHOS mutant links epithelial ER stress and spontaneous lung fibrosis.

Authors:  Jeremy Katzen; Brandie D Wagner; Alessandro Venosa; Meghan Kopp; Yaniv Tomer; Scott J Russo; Alvis C Headen; Maria C Basil; James M Stark; Surafel Mulugeta; Robin R Deterding; Michael F Beers
Journal:  JCI Insight       Date:  2019-03-21

8.  Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice.

Authors:  Elizabeth M Pierce; Kristin Carpenter; Claudia Jakubzick; Steven L Kunkel; Kevin R Flaherty; Fernando J Martinez; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

9.  An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.

Authors:  William D Travis; Ulrich Costabel; David M Hansell; Talmadge E King; David A Lynch; Andrew G Nicholson; Christopher J Ryerson; Jay H Ryu; Moisés Selman; Athol U Wells; Jurgen Behr; Demosthenes Bouros; Kevin K Brown; Thomas V Colby; Harold R Collard; Carlos Robalo Cordeiro; Vincent Cottin; Bruno Crestani; Marjolein Drent; Rosalind F Dudden; Jim Egan; Kevin Flaherty; Cory Hogaboam; Yoshikazu Inoue; Takeshi Johkoh; Dong Soon Kim; Masanori Kitaichi; James Loyd; Fernando J Martinez; Jeffrey Myers; Shandra Protzko; Ganesh Raghu; Luca Richeldi; Nicola Sverzellati; Jeffrey Swigris; Dominique Valeyre
Journal:  Am J Respir Crit Care Med       Date:  2013-09-15       Impact factor: 21.405

10.  Diverse Injury Pathways Induce Alveolar Epithelial Cell CCL2/12, Which Promotes Lung Fibrosis.

Authors:  Jibing Yang; Manisha Agarwal; Song Ling; Seagal Teitz-Tennenbaum; Rachel L Zemans; John J Osterholzer; Thomas H Sisson; Kevin K Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2020-05       Impact factor: 7.748

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.